MYBPHL: A Protein Regulator of Muscle Contraction and Blood Vessel Dynamics

Target Name: MYBPHL

NCBI ID: G343263

MYBPHL

MYBPHL: A Protein Regulator of Muscle Contraction and Blood Vessel Dynamics

Myosin-binding protein H-like (MYBPHL) is a protein that is expressed in various tissues throughout the body, including muscle, heart, and blood vessels. It is a member of the myosin-binding protein (MBP) family, which is a group of transmembrane proteins that play a critical role in the regulation of muscle contraction and relaxation.

MYBPHL is characterized by its unique structure, which consists of a long amino acid sequence that is similar to that of the protein myosin. Myosin is a protein that is found in muscle cells, where it plays a critical role in the regulation of muscle contraction and relaxation. It is composed of two heavy chains and two light chains, and is characterized by its ability to bind to and interact with various regulatory proteins.

MYBPHL is thought to function as a negative regulator of myosin, which means that it works to inhibit the activity of myosin. This is accomplished through a process called protein-protein interaction, which involves the formation of a covalent complex between MYBPHL and myosin.

MYBPHL has been shown to play a critical role in the regulation of muscle contraction and relaxation in various organisms, including mammals. For example, studies have shown thatMYBPHL plays a role in the regulation of muscle contractions in the heart, where it is thought to help to control the rapid and slow contractions that occur during the heartbeat.

MYBPHL has also been shown to be involved in the regulation of blood vessel diameter and blood pressure. This is accomplished through its ability to interact with various proteins that are involved in the regulation of blood vessel diameter and blood pressure, including the protein endothelial nitric oxide receptor (EndoNO).

MYBPHL is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This is the pathway that is responsible for the regulation of cell growth, differentiation, and survival, and is thought to play a critical role in the development and maintenance of tissues.

MYBPHL has also been shown to be involved in the regulation of cellular stress responses, including the production of reactive oxygen species (ROS) and the activation of cellular signaling pathways that are involved in stress responses. This is thought to help to protect cells from the damage that can be caused by ROS, and may be involved in the regulation of cellular stress responses that are critical for the survival and proper functioning of tissues.

In conclusion, MYBPHL is a protein that is characterized by its ability to interact with and regulate the activity of various proteins that are involved in the regulation of muscle contraction and relaxation, blood vessel diameter and blood pressure, cellular signaling pathways, and cellular stress responses. These properties make MYBPHL an attractive potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of MYBPHL in the regulation of these processes, and to determine the best way to use it as a therapeutic tool.

Protein Name: Myosin Binding Protein H Like

Functions: Myosin-binding protein which plays a role in cardiac function (PubMed:28778945). Seems to regulate conduction in the atria and ventricular conduction systems (PubMed:28778945)

The "MYBPHL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYBPHL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets